Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A43501 | 31576541 | Adv Exp Med Biol | Contributing Roles of CYP2E1 and Other Cytochrome P450 Isoforms in Alcohol-Related Tissue Injury and Carcinogenesis. | 2019 | Details |
| A43502 | 31574021 | Surg Laparosc Endosc Percutan Tech | The Effect of Laparoscopic Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A43503 | 31573550 | J Clin Invest | The gut microbiome and metabolic syndrome. | 2019 | Details |
| A43504 | 31570275 | J Hepatol | Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease. | 2019 | Details |
| A43505 | 31566879 | Liver Int | Influence of Helicobacter pylori-connected metabolic syndrome on non-alcoholic fatty liver disease and its related colorectal neoplasm high risk. | 2019 | Details |
| A43506 | 31566590 | Pol Arch Intern Med | Pentraxin 3 in patients with type 2 diabetes and nonalcoholic fatty liver disease: a promising treatment target for glucagon-like peptide-1 receptor agonists. | 2019 | Details |
| A43507 | 31566589 | Pol Arch Intern Med | Pentraxin 3 in patients with type 2 diabetes and nonalcoholic fatty liver disease: a promising treatment target for glucagon-like peptide-1 receptor agonists. Authors' reply. | 2019 | Details |
| A43508 | 31559328 | GE Port J Gastroenterol | Mauriac Syndrome: A Rare Hepatic Glycogenosis in Poorly Controlled Type 1 Diabetes. | 2019 | Details |
| A43509 | 31556117 | J Cell Physiol | Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin. | 2019 | Details |
| A43510 | 31548930 | J Family Med Prim Care | Personal or family history of metabolic traits predispose to higher hepatotoxic effects of alcohol. | 2019 | Details |
| A43511 | 31543242 | Clin Gastroenterol Hepatol | Fibrosis Changes in the Placebo Arm of NASH Clinical Trials. | 2019 | Details |
| A43512 | 31543241 | Clin Gastroenterol Hepatol | Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systemic Review and Meta-analysis. | 2019 | Details |
| A43513 | 31543239 | Clin Gastroenterol Hepatol | Reply. | 2019 | Details |
| A43514 | 31538647 | Clin Infect Dis | Nonalcoholic Fatty Liver Disease in Human Immunodeficiency Virus: The (Not So) New Kid on the Block? | 2020 | Details |
| A43515 | 31538645 | Clin Infect Dis | Reply to Krahn and Sebastiani. | 2020 | Details |
| A43516 | 31534817 | J Sport Health Sci | Exercise as a prescription for patients with various diseases. | 2019 | Details |
| A43517 | 31532559 | Aliment Pharmacol Ther | Editorial: depression in NAFLD-worth looking for. | 2019 | Details |
| A43518 | 31532551 | Aliment Pharmacol Ther | Letter: metformin treatment and hepatocellular carcinoma risk in non-alcoholic fatty liver disease. Authors' reply. | 2019 | Details |
| A43519 | 31532548 | Aliment Pharmacol Ther | Letter: metformin treatment and hepatocellular carcinoma risk in non-alcoholic fatty liver disease. | 2019 | Details |
| A43520 | 31531818 | Dig Dis Sci | Unmasking a Stealth Killer: The Need for Increased Awareness of NASH. | 2020 | Details |
| A43521 | 31531370 | Biomed Res Int | Metabolic Comorbidities and Risk of Development and Severity of Drug-Induced Liver Injury. | 2019 | Details |
| A43522 | 31525802 | Z Gastroenterol | [Screening for patients at risk: value of transient elastography in NAFLD]. | 2019 | Details |
| A43523 | 31521675 | Redox Biol | Corrigendum to "Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy" [Redox Biol. 21 (2019 Feb) 101120]. | 2019 | Details |
| A43524 | 31520612 | Gastroenterology | Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A43525 | 31520590 | Gastrointest Endosc | Endoscopic abdominal exploration in the acute abdomen: No longer a contraindication? | 2019 | Details |
| A43526 | 31520407 | Hepatology | The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis Caused by NASH. | 2019 | Details |
| A43527 | 31519330 | Atherosclerosis | Reply to: "Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in non-alcoholic fatty liver disease". | 2019 | Details |
| A43528 | 31505512 | Med Princ Pract | Reply to the Letter to the Editor "Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease". | 2019 | Details |
| A43529 | 31503304 | JAMA | Trends in Alcoholic Fatty Liver Disease-Reply. | 2019 | Details |
| A43530 | 31503302 | JAMA | Trends in Alcoholic Fatty Liver Disease. | 2019 | Details |
| A43531 | 31503057 | Chin Med J (Engl) | Simultaneous liver transplantation and sleeve gastrectomy: first reported case in East Asia. | 2019 | Details |
| A43532 | 31492444 | Atherosclerosis | Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in non-alcoholic fatty liver disease. | 2019 | Details |
| A43533 | 31485667 | Mol Med Rep | Crosstalk between microRNAs, the putative target genes and the lncRNA network in metabolic diseases. | 2019 | Details |
| A43534 | 31484056 | Cell Metab | Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A43535 | 31483154 | Am J Physiol Regul Integr Comp Physiol | Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity. | 2019 | Details |
| A43536 | 31480433 | Int J Mol Sci | Bone Diseases in Patients with Chronic Liver Disease. | 2019 | Details |
| A43537 | 31475778 | J Cell Mol Med | Protective role of melatonin in early-stage and end-stage liver cirrhosis. | 2019 | Details |
| A43538 | 31474629 | Yakugaku Zasshi | [The Front Line of the NAFLD/NASH Study Reported from the Pharmaceutical Field-Feedback from Basic Research to Medical Treatment and Pharmacist Activity]. | 2019 | Details |
| A43539 | 31466125 | Hepatology | Elevated Fatty Liver Index as a Risk Factor for All-Cause Mortality in Human Immunodeficiency Virus-Hepatitis C Virus-Coinfected Patients (ANRS CO13 HEPAVIH Cohort Study). | 2020 | Details |
| A43540 | 31465427 | PLoS One | Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: The IT-DIAB study. | 2019 | Details |
| A43541 | 31464785 | Eur J Gastroenterol Hepatol | Transient elastography for assessing severe hepatic fibrosis in diabetic patients with nonalcoholic fatty liver disease: definitions matter. | 2019 | Details |
| A43542 | 31464781 | Eur J Gastroenterol Hepatol | Bile acids and butyrate in the effects of probiotics/synbiotics on nonalcoholic fatty liver disease. | 2019 | Details |
| A43543 | 31456234 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease in Asia: How is it different from the West? | 2019 | Details |
| A43544 | 31453710 | Am J Physiol Endocrinol Metab | Gestational hypercholesterolemia alters fetal hepatic lipid metabolism and microRNA expression in Apo-E-deficient mice. | 2019 | Details |
| A43545 | 31450946 | Angiology | Reply to the Letter to the Editor Entitled "NFS Is Not a Marker of Nonalcoholic Fatty Liver Disease Per Se: What Is the True Relationship With CAD Complexity?" | 2019 | Details |
| A43546 | 31446629 | Hepatology | Too Much Sugar-The Not-So-Sweet Reality of Its Impact on Our Health. | 2019 | Details |
| A43547 | 31440486 | J Hepatocell Carcinoma | Status of, and strategies for improving, adherence to HCC screening and surveillance. | 2019 | Details |
| A43548 | 31439937 | Nat Rev Gastroenterol Hepatol | A global view of hepatocellular carcinoma: trends, risk, prevention and management. | 2019 | Details |
| A43549 | 31435194 | Gastroenterol Hepatol (N Y) | Nonalcoholic Fatty Liver Disease and Pregnancy. | 2019 | Details |
| A43550 | 31435162 | World J Gastroenterol | Exhaled breath analysis in hepatology: State-of-the-art and perspectives. | 2019 | Details |
| A43551 | 31434800 | JCI Insight | Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids. | 2019 | Details |
| A43552 | 31434739 | J Biol Chem | Sex-specific hepatic lipid and bile acid metabolism alterations in Fancd2-deficient mice following dietary challenge. | 2019 | Details |
| A43553 | 31434567 | J Transl Med | Correction to: Matrine attenuates endoplasmic reticulum stress and mitochondrion dysfunction in nonalcoholic fatty liver disease by regulating SERCA pathway. | 2019 | Details |
| A43554 | 31432115 | Mol Med Rep | Hepatic NPC1L1 overexpression attenuates alcoholic autophagy in mice. | 2019 | Details |
| A43555 | 31430206 | Expert Opin Investig Drugs | Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1/2 inhibitors. | 2019 | Details |
| A43556 | 31419758 | Cytokine | The association of angiopoietin-like peptide 4 levels with obesity and hepatosteatosis in adolescents. | 2019 | Details |
| A43557 | 31419141 | J Med Chem | Development of the First Low Nanomolar Liver Receptor Homolog-1 Agonist through Structure-guided Design. | 2019 | Details |
| A43558 | 31414538 | Aliment Pharmacol Ther | Editorial: it is not a wide-open field for incretins - collateral benefits favour the use of metformin in advanced non-alcoholic steatohepatitis. | 2019 | Details |
| A43559 | 31411836 | Rev Med Suisse | 2019 | Details | |
| A43560 | 31408938 | Molecules | Resveratrol Maintains Lipid Metabolism Homeostasis via One of the Mechanisms Associated with the Key Circadian Regulator Bmal1. | 2019 | Details |
| A43561 | 31405435 | Am Surg | Combined Liver and Kidney Transplantation in a Patient with Situs Inversus. | 2019 | Details |
| A43562 | 31401364 | Clin Gastroenterol Hepatol | Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. | 2019 | Details |
| A43563 | 31400797 | Am J Med | The Reply. | 2019 | Details |
| A43564 | 31400373 | Gastroenterology | Towards Precision Medicine in Nonalcoholic Fatty Liver Disease with PNPLA3 as a Therapeutic Target. | 2019 | Details |
| A43565 | 31393627 | Hepatology | Letter to the Editor: Re: Noninvasive Tests in Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Critical Insights from STELLAR Trials. | 2020 | Details |
| A43566 | 31390078 | Hepatology | Reply. | 2019 | Details |
| A43567 | 31390074 | Hepatology | Letter to the Editor: Prevalence of NAFLD in China: What Did We Learn From the Recent Meta-Analysis? | 2019 | Details |
| A43568 | 31388093 | Nat Rev Immunol | The intestinal microbiota fuelling metabolic inflammation. | 2019 | Details |
| A43569 | 31385415 | J Med Imaging Radiat Oncol | Incidental hepatic steatosis in radiology reports: a survey of emergency department clinicians' perspectives and current practice. | 2019 | Details |
| A43570 | 31381156 | Hepatology | Noninvasive Tests of Liver Fibrosis and Their Combination in Nonalcoholic Fatty Liver Disease: From Selected Patients to Real-Life Populations. | 2019 | Details |
| A43571 | 31380439 | Biomed Res Int | Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives. | 2019 | Details |
| A43572 | 31378994 | Hepatology | The Underpinnings of PNPLA3-Mediated Fatty Liver Emerge. | 2019 | Details |
| A43573 | 31378113 | J Int Med Res | Tanshinone IIA ameliorates non-alcoholic fatty liver disease through targeting peroxisome proliferator-activated receptor gamma and toll-like receptor 4. | 2019 | Details |
| A43574 | 31373953 | Surg Laparosc Endosc Percutan Tech | Comments on "The Effect of Laparoscopic Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease". | 2019 | Details |
| A43575 | 31372017 | Diabetes Metab Syndr Obes | Smoking results in accumulation of ectopic fat in the liver. | 2019 | Details |
| A43576 | 31369090 | J Clin Endocrinol Metab | Overeating Saturated Fat Promotes Fatty Liver and Ceramides Compared With Polyunsaturated Fat: A Randomized Trial. | 2019 | Details |
| A43577 | 31360687 | J Cancer Prev | Therapeutic Effects of Amino Acids in Liver Diseases: Current Studies and Future Perspectives. | 2019 | Details |
| A43578 | 31359473 | Aliment Pharmacol Ther | Letter: improvement of clinical outcomes by metformin in metabolic liver disease-a microbiota-dependent mechanism? | 2019 | Details |
| A43579 | 31357772 | Zhonghua Gan Zang Bing Za Zhi | [Advances in the study of non-infectious liver diseases and precancerous lesions of hepatocellular carcinoma]. | 2019 | Details |
| A43580 | 31356353 | Curr Opin Pediatr | The good bugs: the use of probiotics in pediatrics. | 2019 | Details |
| A43581 | 31356096 | Arch Iran Med | Comparing Anthropometric Indicators of Visceral and General Adiposity as Determinants of Overall and Cardiovascular Mortality. | 2019 | Details |
| A43582 | 31355732 | Zebrafish | Palmitic Acid-Enriched Diet Induces Hepatic Steatosis and Injury in Adult Zebrafish. | 2019 | Details |
| A43583 | 31355355 | Contact (Thousand Oaks) | Catching Lipid Droplet Contacts by Proteomics. | 2019 | Details |
| A43584 | 31352386 | BMJ Case Rep | Treatment of inoperable hepatocellular carcinoma with immunotherapy. | 2019 | Details |
| A43585 | 31352095 | Clin Gastroenterol Hepatol | Reply. | 2019 | Details |
| A43586 | 31345779 | Lancet Gastroenterol Hepatol | A new bile acid treatment for non-alcoholic fatty liver disease. | 2019 | Details |
| A43587 | 31345023 | J Agric Food Chem | Processed Meat Protein Promoted Inflammation and Hepatic Lipogenesis by Upregulating Nrf2/Keap1 Signaling Pathway in Glrx-Deficient Mice. | 2019 | Details |
| A43588 | 31343751 | Hepatology | Apolipoprotein B and PNPLA3 Double Heterozygosity in a Father-Son Pair With Advanced Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A43589 | 31341440 | Integr Med (Encinitas) | Barrie Tan, PhD: Using Tocotrienols to Address Lifestyle and Metabolic Disease. | 2019 | Details |
| A43590 | 31341105 | JCI Insight | Lipidomics unveils lipid dyshomeostasis and low circulating plasmalogens as biomarkers in a monogenic mitochondrial disorder. | 2019 | Details |
| A43591 | 31337282 | Thyroid | A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia. | 2019 | Details |
| A43592 | 31335359 | Am J Gastroenterol | ACG Clinical Guideline: Hereditary Hemochromatosis. | 2019 | Details |
| A43593 | 31335197 | Diabetes Technol Ther | Evolving Management Strategies for Nonalcoholic Fatty Liver Disease-Targeting Primary Care Physicians. | 2019 | Details |
| A43594 | 31325127 | J Gen Intern Med | Trends in Prevalence of Nonalcoholic Fatty Liver Disease in US Adults with Prediabetes. | 2019 | Details |
| A43595 | 31323122 | Hepatology | Risks of Light and Moderate Alcohol Use in Fatty Liver Disease: Follow-Up of Population Cohorts. | 2019 | Details |
| A43596 | 31319680 | Angiology | The Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases. | 2019 | Details |
| A43597 | 31318706 | Am J Gastroenterol | Evaluating an Outpatient With an Elevated Bilirubin. | 2019 | Details |
| A43599 | 31313369 | Aliment Pharmacol Ther | Letter: use of collagen proportionate area to quantify liver fibrosis and predict clinical outcomes non-alcoholic fatty liver disease-authors' reply. | 2019 | Details |
| A43600 | 31313357 | Aliment Pharmacol Ther | Letter: use of collagen proportionate area to quantify liver fibrosis and predict clinical outcomes in non-alcoholic fatty liver disease. | 2019 | Details |
| A43602 | 31311004 | J Endocrinol | Assessment of mouse liver [1-13C]pyruvate metabolism by dynamic hyperpolarized MRS. | 2019 | Details |